Michael Ellis, DOtrained in internal medicine and now dedicated to wellness and aestheticsour treatments prioritize both safety and results
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for managing type 2 diabetes, though some are now also licensed for weight management
Clinical trials in patients with metabolic syndrome reveal that L-Carnitine supplementation of 2 g/day for extended periods (25-50 weeks) significantly reduces fasting blood glucose, HbA1c, homeostatic model assessment-insulin resistance (HOMA-IR), inflammatory markers including C-reactive protein (CRP) and tumor necrosis factor-alpha (TNF-), and triglyceride levels
Research suggests possible synergistic dynamics, though findings vary across studies
Why it Works Stronger appetite suppression Targets hunger & insulin response Dual-pathway targeting for deeper appetite control Best for Breaking through weight loss plateaus Need stronger appetite control GLP-1 Microdose Plan GLP-1 receptor agonist micro-titration Same medication half the dose, twice a week Step up to a full plan anytime youre ready Start low, go slow
delays in securing reimbursement by public payers